MHC-associated peptide proteomics enabling highly sensitive detection of immunogenic sequences for the development of therapeutic antibodies with low immunogenicity-Reference-Cited by-同舟云学术

MHC-associated peptide proteomics enabling highly sensitive detection of immunogenic sequences for the development of therapeutic antibodies with low immunogenicity

Published:2018-10-01 Issue:8 Volume:10 Page:1168-1181
ISSN:1942-0862
Container-title:mAbs
language:en
Short-container-title:mAbs

Author:

Sekiguchi Nobuo¹,Kubo Chiyomi¹,Takahashi Ayako¹,Muraoka Kumiko¹,Takeiri Akira¹^ORCID,Ito Shunsuke¹,Yano Mariko¹,Mimoto Futa¹,Maeda Atsuhiko¹,Iwayanagi Yuki¹,Wakabayashi Tetsuya¹^ORCID,Takata Shotaro¹,Murao Naoaki¹,Chiba Shuichi¹,Ishigai Masaki¹

Affiliation:

1. Research Division, Fuji Gotemba Research Labs, Chugai Pharmaceutical Co., Ltd., Gotemba, Shizuoka, Japan

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/19420862.2018.1518888

Reference46 articles.

1. Immunotoxicity and Immunogenicity of Biopharmaceuticals: Design Concepts and Safety Assessment

2. Immunogenicity and its Impact on Benefit/Risk Considerations in the Authorisation of Biopharmaceuticals

3. A fit-for-purpose strategy for the risk-based immunogenicity testing of biotherapeutics: a European industry perspective

4. European Medicines Agency, Committee for Medicinal Products for Human Use (CHMP). Guideline on immunogenicity assessment of monoclonal antibodies intended for in vivo clinical use. [Online]. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2012/06/WC500128688.pdf.

5. US Food and Drug Administration, Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER). Guidance for industry; immunogenicity assessment for therapeutics protein products. [Online] https://www.fda.gov/downloads/drugs/guidances/ucm338856.pdf.

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nonclinical immunogenicity risk assessment for knobs-into-holes bispecific IgG ₁ antibodies;mAbs;2024-06-06

2. T and B cell epitope analysis for the immunogenicity evaluation and mitigation of antibody-based therapeutics;mAbs;2024-03-21

3. Protein Profile of Mouse Endolymph Extracts its Protective Role in Controlling the Cochlear Homeostasis;2024

4. Development of a semi-automated MHC-associated peptide proteomics (MAPPs) method using streptavidin bead-based immunoaffinity capture and nano LC-MS/MS to support immunogenicity risk assessment in drug development;Frontiers in Immunology;2023-11-10

5. Characterization and root cause analysis of immunogenicity to pasotuxizumab (AMG 212), a prostate-specific membrane antigen-targeting bispecific T-cell engager therapy;Frontiers in Immunology;2023-10-23